NCT04710251 is a NA clinical trial of Speedometer in Colonic Polyp, sponsored by Norwegian Department of Health and Social Affairs.

Who is sponsoring NCT04710251?

NCT04710251 is sponsored by Norwegian Department of Health and Social Affairs.

What drugs are being tested in NCT04710251?

Interventions in NCT04710251: Speedometer.

What condition does NCT04710251 study?

NCT04710251 studies Colonic Polyp, Colonic Adenoma, Adenoma Colon.

Is NCT04710251 still recruiting?

NCT04710251 is currently status unknown. Last updated 14 January 2021.

Last reviewed 2021-01-14 · How we verify

NCT04710251

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effectiveness of Using the Speedometer During Colonoscopy

Status unknown NA Last updated 14 January 2021

What this trial tests

NA trial testing Speedometer in Colonic Polyp in 332 participants. Status unknown.

Timeline

1 March 2021

Primary endpoint
30 June 2021

31 December 2022

Quick facts

Lead sponsor	Norwegian Department of Health and Social Affairs
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	non randomized
Design	sequential
Masking	double
Primary purpose	diagnostic
Enrollment	332
Start date	1 March 2021
Primary completion	30 June 2021
Estimated completion	31 December 2022

Drugs / interventions tested

Speedometer

Conditions studied

Colonic Polyp — all drugs for Colonic Polyp →
Colonic Adenoma — all drugs for Colonic Adenoma →
Adenoma Colon — all drugs for Adenoma Colon →

Sponsor

Norwegian Department of Health and Social Affairs

Who can join

18 and older, any sex, with Colonic Polyp or Colonic Adenoma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

PURPOSE OF PROTOCOL Objective: To evaluate if the speedometer based on the real-time image analysis can help endoscopists increase their withdrawal time, which is defined as time spent examining the colon during withdrawal of the colonoscope, during colonoscopy. Hypothesis: The trial hypothesis is that use of the speedometer during colonoscopy will increase the average withdrawal time, which is defined as time spent examining the colon during withdrawal of the colonoscope, by 1.6 minutes, possibly increasing the performance of the participating endoscopists. Our objective is to clarify the clinical benefits of this digital tool in colonoscopy. Endpoint: Withdrawal time difference between colonoscopies done without the speedometer (control period) and colonoscopies done with the speedometer (intervention period).

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Speedometer for withdrawal time monitoring during colonoscopy: a clinical implementation trial.
Barua I, Misawa M, Glissen Brown JR, Walradt T, et al · · 2023 · cited 10× · PMID 36519564 · DOI 10.1080/00365521.2022.2154616

Verify or expand the search:

Other recruiting trials for Colonic Polyp

Currently open trials in the same condition.

NCT06550908 — Training Physicians to Differentiate the Paris Classification Using Artificial Colon Polyp Images · NA · recruiting
NCT07456111 — A Comparison of Remimazolam Besylate and Propofol Sedation in Patients Undergoing Colonoscopic Polypectomy · Phase 4 · recruiting
NCT06483503 — Extra Wide Field of View Lens Study · active not recruiting
NCT06077435 — Comparative Analysis of AI Software for Enhanced Polyp Detection and Diagnosis · NA · recruiting

Other Norwegian Department of Health and Social Affairs trials

Trials by the same sponsor.

NCT06940947 — Endoscopic Therapy Or Surgery for Early Colon Cancer · Phase 3 · recruiting
NCT04406909 — Rapid-Cycle Re-Implementation of TRAining Facilities in Norway · NA · unknown
NCT03576833 — The BALLOON- (BALLOon Treatment for Obesity in Norway) Pilot Study · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04710251 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Norwegian Department of Health and Social Affairs
Last refreshed: 14 January 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04710251.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing